Stay updated on Phase 2 DaxibotulinumtoxinA Clinical Trial
Sign up to get notified when there's something new on the Phase 2 DaxibotulinumtoxinA Clinical Trial page.

Latest updates to the Phase 2 DaxibotulinumtoxinA Clinical Trial page
- Check7 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new version of the ClinicalTrials.gov record that likely reflects small edits to the page without changing the study details.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page’s footer has been updated to reflect a new ClinicalTrials.gov release/build revision (moving from v3.5.0 to v3.5.3). This reflects a platform or site update rather than a change to the study details.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This is a version bump reflecting an update to the page's metadata.SummaryDifference0.1%

- Check71 days agoChange DetectedResults-related information and updated study dates were added to the page.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No visible changes to the study content or primary user-facing features.SummaryDifference0.1%

- Check100 days agoChange DetectedRevision: v3.4.2 is now live, replacing v3.4.1. No study content or core functionality appears to be altered.SummaryDifference0.1%

Stay in the know with updates to Phase 2 DaxibotulinumtoxinA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2 DaxibotulinumtoxinA Clinical Trial page.